BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29348638)

  • 1. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.
    Leem AY; Song JH; Lee EH; Lee H; Sim B; Kim SY; Chung KS; Kim EY; Jung JY; Park MS; Kim YS; Chang J; Kang YA
    Sci Rep; 2018 Jan; 8(1):1159. PubMed ID: 29348638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.
    Kimuda SG; Andia-Biraro I; Egesa M; Bagaya BS; Raynes JG; Levin J; Elliott AM; Cose S
    PLoS One; 2017; 12(11):e0188396. PubMed ID: 29161328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoarabinomannan-specific TNF-α and IFN-γ as markers of protective immunity against tuberculosis: a cohort study in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Bjune G; Abebe F
    APMIS; 2015 Oct; 123(10):851-7. PubMed ID: 26200933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variation.
    Mensah GI; Addo KK; Tetteh JA; Sowah S; Loescher T; Geldmacher C; Jackson-Sillah D
    BMC Infect Dis; 2014 Sep; 14():495. PubMed ID: 25209422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection.
    Siddiqui S; Sarro Y; Diarra B; Diallo H; Guindo O; Dabitao D; Tall M; Hammond A; Kassambara H; Goita D; Dembele P; Traore B; Hengel R; Nason M; Warfield J; Washington J; Polis M; Diallo S; Dao S; Koita O; Lane HC; Catalfamo M; Tounkara A
    Clin Immunol; 2015 Jul; 159(1):1-12. PubMed ID: 25889622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood cytokine responses to early secreted protein antigen-6/culture filtrate protein-10 tuberculosis antigens 2 months after antituberculosis treatment among patients with drug-susceptible pulmonary tuberculosis.
    Mvungi HC; Mbelele PM; Buza JJ; Mpagama SG; Sauli E
    Int J Mycobacteriol; 2019; 8(1):53-59. PubMed ID: 30860180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.
    Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Russomando G; Acosta CCD; Arenas R; Ranaivomanana PP; Razafimahatratra C; Herindrainy P; Rakotonirina J; Raherinandrasana AH; Rakotosamimanana N; Hamze M; Ismail MB; Bayaa R; Berland JL; De Maio F; Delogu G; Endtz H; Ader F; Goletti D; Hoffmann J
    Front Immunol; 2020; 11():616450. PubMed ID: 33603746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
    Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
    Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
    J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2014; 9(11):e113101. PubMed ID: 25415590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo responses for interferon-gamma and proinflammatory cytokine secretion to low-molecular-weight antigen MTB12 of Mycobacterium tuberculosis during human tuberculosis.
    Lee JS; Son JW; Jung SB; Kwon YM; Yang CS; Oh JH; Song CH; Kim HJ; Park JK; Paik TH; Jo EK
    Scand J Immunol; 2006 Aug; 64(2):145-54. PubMed ID: 16867160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.